Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > BAYRY BAYER AG > Key Indicators
BAYRY BAYER AG
13.890
-0.080-0.57%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
-0.29% 206.961 0.32% 217.0502 0.93% 186.9579 0.93% 186.9579
Receivable Turnover(T)
9.01% 3.4714 12.26% 3.3649 15.34% 4.4976 15.34% 4.4976
Inventory Turnover(T)
-11.90% 1.7146 -13.48% 1.6219 -14.13% 1.5133 -14.13% 1.5133
Fixed Assets Turnover(T)
9.43% 3.8524 10.32% 3.7723 5.56% 3.6135 5.56% 3.6135
Total Asset Rate(T)
13.57% 0.3976 13.33% 0.3794 9.18% 0.3715 9.18% 0.3715
ROIC
423.45% 16.468% 139.42% 8.456% 120.15% 2.352% 120.15% 2.352%
ROE
252.71% 12.393% 125.71% 6.115% 111.68% 3.147% 111.68% 3.147%
ROA
254.72% 3.486% 122.23% 1.801% 109.77% 0.843% 109.77% 0.843%
FCF to Sales
-- 9.403% 35,935.32% 9.694% -6.35% 5.622% -6.35% 5.622%
FCF to Net Income
-- 107.266% -- 204.223% -- 247.800% -- 247.800%
Efficiency Ratios
ROE 5 Year Average
-- -- -- -- -55.22% 2.182% -- --
ROA 5 Year Average
-- -- -- -- -43.42% 1.293% -- --
Average 5 Years ROIC
-- -- -- -- -35.11% 3.310% -- --
Profitability Ratios TTM
Gross Margin
17.40% 61.892% 18.15% 62.722% 15.02% 61.852% 15.02% 61.852%
Operating Margin
7.97% 21.689% 5,548.52% 17.326% 1,008.81% 15.673% 1,008.81% 15.673%
Net Margin
236.24% 8.766% 119.61% 4.747% 108.95% 2.269% 108.95% 2.269%
EBITDA Margin
30.14% 0.2218% 439.67% 0.1627% 352.89% 0.1463% 352.89% 0.1463%
R & D Expense Ratio
-31.48% 12.320% -28.87% 12.220% -28.65% 12.280% -28.65% 12.280%
Sales Expense Ratio
-10.00% 28.000% -12.86% 27.520% -11.04% 28.050% -11.04% 28.050%
Administration Expense Rate
-7.04% 6.070% -2.87% 6.430% -3.31% 6.720% -3.31% 6.720%
Financial Health Ratios
Long-Term Debt to Equity Ratio
-- -- -- -- 1.59% 110.472% 1.59% 110.472%
Total Assets to Common Equity
-10.03% 338.762% -2.16% 335.983% -5.04% 364.146% -5.04% 364.146%
Debt to Asset Ratio
-- -- -- -- -12.06% 119.718% -12.06% 119.718%
Current Ratio
1.17% 1.1756 -0.35% 1.233 14.12% 1.108 14.12% 1.108
Quick Ratio
-2.52% 0.737 -4.93% 0.7896 3.90% 0.6281 3.90% 0.6281
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- -- -- -36.43% 3.650% -- --
Revenue CAGR(5Y)
-- -- -- -- 47.05% -1.177% -- --
Net Income CAGR(3Y)
-- -- -- -- -- -16.129% -- --
Net Income CAGR(5Y)
-- -- -- -- -- -26.080% -- --
Dividend CAGR(3Y)
-- -- -- -- -1,075.27% -11.111% -- --
Dividend CAGR(5Y)
-- -- -- -- -205.62% -4.800% -- --
FCF 1 Year Growth
-- -- -- -- 99.49% -0.282% -- --
FCF CAGR(3Y)
-- -- -- -- 8.05% -22.502% -- --
FCF CAGR(5Y)
-- -- -- -- -64.38% -17.569% -- --
Currency Unit
EUREUREUREUR

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.
CEO: --
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist